Allogeneic stem cell transplantation (AlloSCT) in patients with lymphoma relapsing after autologous SCT (AutoSCT)

被引：0
|
作者：
Bogdanic, V [1 ]
Auer, I [1 ]
Nemet, D [1 ]
Mrsic, M [1 ]
Labar, B [1 ]
机构：
[1] Univ Hosp, Ctr Rebro, Dept Internal Med, Div Hematol, Zagreb, Croatia
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
510
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [1] Allogeneic stem cell transplantation (AlloSCT) in patients with lymphoma relapsing after autologous SCT (AutoSCT)
    Aurer, I
    Bogdanic, V
    Nemet, D
    Mrsic, M
    Labar, B
    ANNALS OF ONCOLOGY, 1998, 9 : 114 - 114
  • [2] Allogeneic Hematopoietic Stem Cell Transplantation for Follicular Lymphoma Relapsing after Autologous Transplantation
    Sakurai, Masatoshi
    Mori, Takehiko
    Shiratori, Souichi
    Wakayama, Toshio
    Uchida, Naoyuki
    Kobayashi, Hikaru
    Kanda, Junya
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Kondo, Eisei
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 512 - 512
  • [3] Patients with mantle-cell lymphoma relapsing after autologous stem cell transplantation may be rescued by allogeneic transplantation
    C Martínez
    E Carreras
    M Rovira
    Á Urbano-Ispizua
    J Esteve
    M Perales
    F Fernández
    E Montserrat
    Bone Marrow Transplantation, 2000, 26 : 677 - 679
  • [4] Patients with mantle-cell lymphoma relapsing after autologous stem cell transplantation may be rescued by allogeneic transplantation
    Martínez, C
    Carreras, E
    Rovira, M
    Urbano-Ispizua, A
    Esteve, J
    Perales, M
    Fernández, F
    Montserrat, E
    BONE MARROW TRANSPLANTATION, 2000, 26 (06) : 677 - 679
  • [5] Allogeneic cell therapy (ACT) after relapse from autologous stem cell transplantation (autoSCT).
    Porter, D
    Luger, S
    Duffy, K
    Orloff, G
    Tsai, D
    Stadtmauer, E
    Laport, G
    Schuster, S
    McDaid, K
    Kathakali, A
    Leonard, D
    Antin, J
    BLOOD, 2000, 96 (11) : 195A - 195A
  • [6] A pilot study of myeloablative (MA) autologous stem cell transplantation (AutoSCT) followed by reduced intensity (RI) allogeneic transplantation (AlloSCT) in children and young adults with relapsed lymphoma
    Bradley, MB
    Harrison, L
    George, D
    Garvin, J
    Del Toro, G
    Wolownik, K
    Wischhover, C
    Cheung, YK
    Weiner, M
    Kelly, K
    Skerrett, D
    Schiff, P
    Cairo, MS
    PEDIATRIC RESEARCH, 2003, 53 (04) : 275A - 275A
  • [7] Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
    Evgenii Shumilov
    Inna Shakhanova
    Johanna Flach
    Nicole Schmidt
    Susanne Buerki
    Myriam Legros
    Marie-Noëlle Kronig
    Yishai Ofran
    Sabine Gerull
    Michael Medinger
    Behrouz Mansouri Taleghani
    Jakob Passweg
    Jörg Halter
    Ulrike Bacher
    Thomas Pabst
    Bone Marrow Transplantation, 2022, 57 : 224 - 231
  • [8] Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
    Shumilov, Evgenii
    Shakhanova, Inna
    Flach, Johanna
    Schmidt, Nicole
    Buerki, Susanne
    Legros, Myriam
    Kronig, Marie-Noelle
    Ofran, Yishai
    Gerull, Sabine
    Medinger, Michael
    Taleghani, Behrouz Mansouri
    Passweg, Jakob
    Halter, Joerg
    Bacher, Ulrike
    Pabst, Thomas
    BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 224 - 231
  • [9] A pilot study of myeloablative (MA) autologous stem cell transplantation (AutoSCT) followed by reduced intensity (RI) allogeneic transplantation (AlloSCT) in children and young adults with relapsed/refractory lymphoma
    Bradley, MB
    Cooney, E
    Harrison, L
    George, D
    Garvin, J
    Del Toro, G
    Bessmertny, O
    Cheung, YK
    Weiner, M
    Kelly, K
    Gewanter, R
    Skerrett, D
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 70 - 70
  • [10] Allogeneic stem cell transplantation as salvage treatment for relapse after autologous transplantation (autoSCT) in chronic lymphocytic leukaemia: outcome and impact of remission duration after autoSCT
    Dreger, P.
    van Biezen, A.
    Michallet, M.
    Brand, R.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S238 - S238
12345